Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday&#39

LITTLETON, Colo., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or “the Compan

Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday&#

Arista Networks Inc (ANET) reported strong Q2 results, with revenue of $3.04B, up 37.7% YoY. Shares

Gainers Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 42.0% to $1.42 during Tuesday'

Gainers Alzamend Neuro (NASDAQ:ALZN) stock increased by 12.9% to $1.35 during Tuesday's after-m

LITTLETON, Colo., June 30, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Compan

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 40.3% to $4.56 during Tuesday's after-m

Vivos and Streeterville Extend Timeframe of Financing Agreement and Reaffirm Commitment to Convert D

LITTLETON, Colo., June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Compan

Vivos Announces Collaboration Agreement with Florida Cardiology Group to Extend Sleep Apnea and Inso

LITTLETON, Colo., June 08, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Compan

Vivos Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Stre

Vivos Therapeutics, Inc. (VVOS) Q1 2026 Earnings Call Transcript

Year-over-year revenue increased 70%, reflecting contribution from Vivos' acquisition of The Sleep C

Some of Wall Street's biggest upside calls are not sitting in the mega-cap names. They are hiding in

Wall Street analysts changed their outlook on top names. For all rating changes, see analyst ratings

Vivos Therapeutics (NASDAQ: VVOS) executives told investors the company's shift toward a medical pro

Vivos Therapeutics, Inc. (VVOS) Q4 2025 Earnings Call Transcript

Full Year 2025 revenue increased 16% Integration of The Sleep Center of Nevada and shift in business

LITTLETON, Colo., April 15, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Compa

Vivos Therapeutics, Inc. (NASDAQ: VVOS - Get Free Report) was the target of a large decline in short

LITTLETON, Colo., April 07, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Compa

Applied Optoelectronics Inc (NASDAQ: AAOI) rose in pre-market trading after securing an 800G transce

Vivos Therapeutics, Inc. (NASDAQ: VVOS - Get Free Report) major shareholder Michael Skaff bought 1,3

Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status A

Vivos Therapeutics, Inc. (NASDAQ: VVOS - Get Free Report) shares traded up 1.5% during trading on We

LITTLETON, Colo., March 17, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Compa

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the compa

Gainers Harbor Custom Development, Inc. (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Th

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $

  During the session on Thursday, 461 stocks hit new 52-week lows.

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q